Marvell Up 207% as AI Demand Soars

Marvell's data center biz is on fire. Even with tech stocks down, they're crushing it. Stock soared over 207% last year. Earnings beat expectations. Revenue up 28%. AI demand is the secret sauce. CEO says they're in a "growth period." But what's next if the tech slump continues?

Insulet's recalling 7M insulin pumps. Potential leaks could trigger severe complications. 24 serious cases already. No deaths, but $50M in costs loom. Yet, they claim no hit to 2026 forecasts. How can a $50M recall not shake their outlook?

JPMorgan's big surprise: a $1 billion expense shock. Margin squeeze fears rise. Dimon's M&A hints with $20B potential can't calm jittery investors. Strong trading outlook? Not enough. Why is JPM stock dipping despite solid numbers?